Duke University School of Medicine was awarded more than $527 million in federal funding from the National Institutes of Health (NIH) in 2022, ranking ninth nationally among academic medical centers, according to the Blue Ridge Institute for Medical Research.
The Blue Ridge ranking — an annual, independent analysis of NIH research funds to colleges and universities — reports eight clinical science departments and two basic science departments in the School of Medicine among the top 10 in the country:
- 1st for Orthopaedics
- 1st for Surgery
- 2nd for Anesthesiology
- 2nd for Pediatrics
- 5th for Internal Medicine
- 5th for Neurosurgery
- 8th for Genetics
- 8th for Pharmacology
- 8th for Psychiatry
- 10th for Ophthalmology
Duke has ranked in the top 10 in NIH research funding nationally in 19 of the last 22 years.
“Duke scientists are making an enormous difference in advancing scientific knowledge and improving human health,” said School of Medicine Dean Mary E. Klotman, MD. “Their consistently strong record of research funding is a testament to their excellence and innovation, and I am proud of our faculty, students, and staff for their commitment to biomedical science in service to society.”
The NIH is the largest public funder of biomedical research in the world, investing more than $45 billion in 2022 to advance research aimed at improving health.